NDC 55466-149-22 - Oseltamivir Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55466-149
- Requested NDC
- 55466-149-22
- Package NDCs from labels
- 55466-149-22
- Manufacturer
- Neolpharma, Inc.
- Effective date
- 2024-05-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oseltamivir Phosphate - Neolpharma, Inc. | Neolpharma, Inc. | 2024-05-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55466-149-22 | Oseltamivir Phosphate | 10 in 1 BOTTLE | CAPSULE | 10 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | A-S Medication Solutions | a0f71ac9-136c-4c8d-b30d-b8d08767c206 | 2023-11-16 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 8e81aaa7-7c40-4b05-b19a-cc70edd1d9f9 | 2023-11-01 | Warnings, Adverse reactions | 728109 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Exelan Pharmaceuticals, Inc. | 9fb09e82-42ef-4a2a-9bcd-3aab3ac52bb3 | 2023-11-01 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | A-S Medication Solutions | 91eadf0b-5f04-4f5d-b095-02c5736a3647 | 2023-10-23 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Asclemed USA, Inc. | 78f85d27-9935-4775-b8d7-275e11429b76 | 2023-09-02 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | A-S Medication Solutions | 5194bb90-0876-48c4-a967-c862fbccd110 | 2023-07-06 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Lannett Company, Inc. | 00e2e995-6296-b544-e063-6294a90a8345 | 2023-05-15 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Cipla USA, Inc | 7d04f367-8f62-4f63-bac9-717d14f555a5 | 2023-05-02 | Warnings, Adverse reactions | 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Zydus Pharmaceuticals USA Inc. | 432d9e7b-9cb2-4b7d-9fb2-015449096757 | 2023-03-13 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | A-S Medication Solutions | 73d7fa5a-8304-44b7-9456-58926a265d81 | 2023-02-06 | Warnings, Adverse reactions | 4A3O49NGEZ |
| OSELTAMIVIR | OSELTAMIVIR | Alembic Pharmaceuticals Limited | 0a7181a6-e9eb-4047-a26f-4268f174db16 | 2023-01-30 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Zydus Pharmaceuticals USA Inc. | 0e666061-1bfd-48cd-896b-ded8298a1847 | 2022-12-27 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | cd0236c6-317c-47b1-9185-3253dba4bb37 | 2022-11-01 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| oseltamavir phosphate | OSELTAMAVIR PHOSPHATE | Proficient Rx LP | 09e119eb-a8fa-4635-96a7-1b134593cdca | 2022-11-01 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Amneal Pharmaceuticals NY LLC | c1a280d0-4ce9-494a-9924-eb5621ce3757 | 2022-09-30 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Asclemed USA, Inc. | 00be0870-2ebb-46e3-9e98-a8f068ec664a | 2022-09-22 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 1f754ad7-9df0-4121-8051-0a09491be3c7 | 2022-09-01 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | c754c2f7-7109-4498-aeee-c8ee088dfa98 | 2022-09-01 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR | Amneal Pharmaceuticals NY LLC | d306e22c-0cb8-46cb-9a40-8194a2bc9e85 | 2022-08-30 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 8d264c73-4dd9-4f7c-8a18-f31195cdd013 | 2022-08-01 | Warnings, Adverse reactions | 728113 4A3O49NGEZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.